ENGN (enGene Holdings Inc.) Stock Financials & Earnings | Market Cap Arena

ENGN (enGene Holdings Inc.) Stock Financials & Earnings | Market Cap Arena

ENGNenGene Holdings Inc.

Mkt Cap$359M

Healthcare·Biotechnology·🇨🇦 Canada·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$11M

EPS (TTM)-$0.36

Free Cash Flow (TTM)-$104M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-100.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 23	$0	$0	-$5M
Q3 23	$0	$0	-$6M
Q4 23	$0	$0	-$10M
Q1 24	$0	-$80K	-$11M
Q2 24	$0	-$78K	-$17M
Q3 24	$0	-$82K	-$17M
Q4 24	$480K	$240K	-$17M
Q1 25	$0	-$102K	-$27M
Q2 25	$0	-$106K	$27M
Q3 25	$0	-$130K	$30M
Q4 25	$0	-$171K	-$39M
Q1 26	$0	$0	$31M

Valuation

Quarter	P/S	P/E
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	747.1x	—
Q1 25	747.1x	—
Q2 25	747.1x	—
Q3 25	747.1x	—
Q4 25	—	—
Q1 26	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 23	-$4M	-$4M
Q3 23	-$7M	-$7M
Q4 23	-$7M	-$7M
Q1 24	-$7M	-$8M
Q2 24	-$14M	-$14M
Q3 24	-$7M	-$7M
Q4 24	-$20M	-$20M
Q1 25	-$26M	-$26M
Q2 25	-$23M	-$23M
Q3 25	-$26M	-$26M
Q4 25	-$25M	-$25M
Q1 26	-$29M	-$29M

Capital Expenditures

CapEx

Quarter	CapEx
Q2 23	$10K
Q3 23	$157K
Q4 23	$138K
Q1 24	$506K
Q2 24	$179K
Q3 24	$2K
Q4 24	$238K
Q1 25	$299K
Q2 25	$45K
Q3 25	$704K
Q4 25	$437K
Q1 26	$153K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 23	—	+11.9%
Q3 23	—	+17.8%
Q4 23	—	+59.7%
Q1 24	—	+132.5%
Q2 24	—	+265.4%
Q3 24	—	+168.2%
Q4 24	—	+71.8%
Q1 25	—	+147.0%
Q2 25	—	-256.7%
Q3 25	—	-278.7%
Q4 25	-100.0%	+120.1%
Q1 26	—	-217.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 23	$39K	—
Q3 23	$37K	—
Q4 23	$3M	—
Q1 24	$291K	—
Q2 24	$2M	—
Q3 24	$1M	—
Q4 24	$2M	345.0%
Q1 25	$2M	—
Q2 25	$3M	—
Q3 25	$3M	—
Q4 25	$3M	—
Q1 26	$3M	—

OpEx Breakdown

Quarter	R&D	G&A
Q2 23	$3M	$1M
Q3 23	$4M	$2M
Q4 23	$6M	$4M
Q1 24	$6M	$4M
Q2 24	$10M	$6M
Q3 24	$12M	$7M
Q4 24	$11M	$8M
Q1 25	$20M	$6M
Q2 25	$20M	$7M
Q3 25	$23M	$7M
Q4 25	$32M	$8M
Q1 26	$22M	$9M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 23	$474K	$0	$474K
Q3 23	$269K	$0	$269K
Q4 23	$82M	$0	$82M
Q1 24	$86M	$79K	$86M
Q2 24	$265M	$75K	$265M
Q3 24	$258M	$75K	$258M
Q4 24	$173M	$65M	$238M
Q1 25	$62M	$152M	$214M
Q2 25	$58M	$160M	$217M
Q3 25	$33M	$169M	$202M
Q4 25	$50M	$144M	$194M
Q1 26	$37M	$239M	$276M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q2 23	16M	+0.0%
Q3 23	16M	+0.0%
Q4 23	31M	+98.0%
Q1 24	23M	-25.9%
Q2 24	39M	+70.0%
Q3 24	44M	+12.0%
Q4 24	45M	+2.1%
Q1 25	51M	+13.0%
Q2 25	51M	+0.1%
Q3 25	51M	+0.2%
Q4 25	51M	+0.4%
Q1 26	67M	+31.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 20	—	—
FY 21	—	—
FY 22	—	—
FY 23	$0	33
FY 24	$0	57
FY 25	$0	730K